IXICO and VirtualScopics today signed an Alliance Framework Agreement

IXICO plc (Ticker: IXI) (“IXICO” or the “Company”), the brain health company, and VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today said they have signed an Alliance Framework Agreement and Master Subcontractor Agreement previously announced as an agreement in principle on March 7, 2014. This alliance will provide the clinical trials industry with global operational capabilities and a full range of therapeutic areas and modality expertise. The alliance enhances both companies’ abilities to deliver world-class services to pharmaceutical, biotech and academic customers and collaborators around the globe.

“We believe that this alliance brings together two highly aligned organizations, each with a strong track record of supplying imaging services and technologies to global pharmaceutical companies,” explained Derek Hill, chief executive officer of IXICO. “By combining our resources with those of VirtualScopics we can enhance our ability to deliver on the largest clinical trials world-wide, across a more diverse range of therapeutic areas. Finalizing this agreement marks significant progress in integrating our business development and operational delivery, and in getting our teams to work effectively together.”

PRESS RELEASE
By |2017-10-11T12:36:54+00:0027 June 2014|Collaboration|